Information Provided By: 
Fly News Breaks for September 20, 2016
ISRG
Sep 20, 2016 | 08:20 EDT
Following his firm's semi-annual urology survey and gynecology survey, Citi analyst Amit Hazan believes more procedure upside for Intuitive Surgical looks likely. The results point to continued strength in Intuitive's legacy categories that make up nearly 70% of its U.S. procedures, Hazan tells investors in a research note. He keeps a Buy rating on the shares with a $779 price target.
News For ISRG From the Last 2 Days
